Dudediligence.

Korsana Biosciences, Inc

KRSANASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$194,000Sep ’24$1.8MDec ’24$81,000Mar ’25$93,000Jun ’25$875,000Sep ’25$1.0MDec ’25$0.00Mar ’26
Net income, by quarter
−$723,000Sep ’24$530,000Dec ’24−$1.4MMar ’25−$324,000Jun ’25−$976,000Sep ’25−$799,000Dec ’25−$3.2MMar ’26−$1.8MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$3.9M$297,000$0.00$2.0M$2.1M
Operating income−$55.2M−$18.5M−$13.0M−$3.6M−$5.0M
Net income−$51.6M−$44.1M−$5.3M−$3.1M−$3.5M
Operating cash flow−$36.5M−$40.6M−$21.2M−$4.3M−$3.3M
Free cash flow−$36.5M−$40.6Mnone on filenone on filenone on file
Cash$54.0M$13.4M$7.6M$3.2M$3.2M
Debt$3.5M$3.5Mnone on filenone on filenone on file
Shares outstanding43.4M2.2M2.5M2.5M3.8M